Actively Recruiting
Investigating Perspectives of Patients With Genodermatosis and Healthcare Professionals on Reproductive Counselling
Led by Maastricht University Medical Center · Updated on 2025-05-18
25
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study focuses on patients with genodermatoses and their partners who wish to have children, exploring their decision-making process and views on reproductive options. It also aims to understand how well healthcare professionals such as clinical geneticists and dermatologists are informed about these reproductive choices and how they counsel patients. The study covers various genodermatoses groups including keratinisation disorders, skin fragility diseases, ectodermal dysplasias, dermato-oncogenetic syndromes, and others. Participants will take part in individual semi-structured qualitative interviews to share their perspectives on reproductive decision-making and counselling. The study includes affected patients and partners, as well as healthcare professionals involved in the care of genodermatosis patients. These interviews aim to gather detailed insights from each group regarding their knowledge and views on reproductive options. During the study, researchers will assess the perspectives of patients, partners, and healthcare providers concerning reproductive decisions. This assessment will take place over one day per participant. The study is led by Maastricht University Medical Center and involves no treatment interventions, focusing solely on interviews to collect qualitative data. Participation involves sharing personal views and experiences related to reproductive counselling.
CONDITIONS
Brief Title
Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients with genodermatosis (keratinisation disorders, skin fragility diseases, ectodermal dysplasias, dermato-oncological syndromes, or other genodermatoses) who wish to have children
- If applicable, the partner of a patient who wishes to have children
- Patients with clinically and molecularly confirmed genodermatosis
- Healthcare professionals involved in the care of genodermatosis patients (e.g., clinical geneticists, dermatologists)
You will not qualify if you...
- Inability to communicate verbally in Dutch or English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote)
Duration - 1 day
Participants take part in a qualitative interview to share their perspectives on reproductive decision-making and counselling related to genodermatoses.
1 interview session (in-person or remote)
Trial Site Locations
Total: 1 location
1
Maastricht University Medical Center
Maastricht, Limburg, Netherlands, 6202 AZ
Actively Recruiting
Research Team
F
Fauve C van Veen, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here